UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Efficacité de Dérinox ® chez des patients souffrant d’une rhinite virale évaluée par un PNIF (Peak Nasal Inspiratory Flow)

Annales d'oto-laryngologie et de chirurgie cervico-faciale, 2005-11, Vol.122 (5), p.246-255

2005

Volltextzugriff (PDF)

A randomized controlled clinical trial evaluating the performance and safety of platelets treated with MIRASOL pathogen reduction technology

Transfusion (Philadelphia, Pa.), 2010-11, Vol.50 (11), p.2362-2375

2010

Volltextzugriff (PDF)

Maintenance of remission and monotherapy status over 66 months in patients with psoriatic arthritis receiving etanercept

Clinical and experimental rheumatology, 2016-11, Vol.34 (6), p.1094

2016

Volltextzugriff (PDF)

Nitric oxide: A new messenger in the brain

Neuroscience and biobehavioral reviews, 1993, Vol.17 (4), p.373-384

1993

Volltextzugriff (PDF)

New Pyridobenzodiazepine Derivatives: Modifications of the Basic Side Chain Differentially Modulate Binding to Dopamine (D4.2, D2L) and Serotonin (5-HT2A) Receptors

Journal of medicinal chemistry, 2002-11, Vol.45 (23), p.5136-5149

2002

Volltextzugriff (PDF)

B22 THAT'LL BE THE DAY: UNDERSTANDING IPF RISK FACTORS AND OUTCOMES: A European Pooled Analysis Of Epidemiological Registries In Idiopathic Pulmonary Fibrosis (ipf): Demographics And Baseline Characteristics

American journal of respiratory and critical care medicine, 2015-01, Vol.191, p.1

2015

Volltextzugriff (PDF)

Pyridobenzoxazepine and Pyridobenzothiazepine Derivatives as Potential Central Nervous System Agents: Synthesis and Neurochemical Study

Journal of medicinal chemistry, 1994-02, Vol.37 (4), p.519-525

1994

Volltextzugriff (PDF)

Electrooxidation Potential as a Tool in the Early Screening for New Safer Clozapine-like Analogues

Journal of medicinal chemistry, 2001-03, Vol.44 (5), p.769-776

2001

Volltextzugriff (PDF)

Dopamine D4 receptors: a new opportunity for research on schizophrenia

Current medicinal chemistry, 1998-04, Vol.5 (2), p.77-100

1998

Volltextzugriff (PDF)

JL13, A PYRIDOBENZOXAZEPINE COMPOUND WITH POTENTIAL ATYPICAL ANTIPSYCHOTIC ACTIVITY: A REVIEW OF ITS BEHAVIOURAL PROPERTIES

Pharmacological research, 1997-10, Vol.36 (4), p.255-264

1997

Volltextzugriff (PDF)

Minimal effects of JL 13, a pyridobenzoxazepine derivative with an antipsychotic potential, on circulating prolactin levels in male rats

Neuroscience letters, 2002-02, Vol.319 (1), p.49-52

2002

Volltextzugriff (PDF)

Oxidation Sensitivity May Be a Useful Tool for the Detection of the Hematotoxic Potential of Newly Developed Molecules: Application to Antipsychotic Drugs

Archives of biochemistry and biophysics, 1999-10, Vol.370 (1), p.126-137

1999

Volltextzugriff (PDF)

The inclusion of fluoxetine into γ-cyclodextrin increases its bioavailability : behavioural, electrophysiological and pharmacokinetic studies

Psychopharmacologia, 2000-09, Vol.151 (4), p.328-334

2000

Volltextzugriff (PDF)

Double-blind randomized controlled study of the efficacy and tolerability of two reversible monoamine oxidase A inhibitors, pirlindole and moclobemide, in the treatment of depression

Acta psychiatrica Scandinavica, 1997-08, Vol.96 (2), p.134-141

1997

Volltextzugriff (PDF)

JL 13, a Potential Successor to Clozapine, Is Less Sensitive to Oxidative Phenomena

Biochemical and biophysical research communications, 1997-09, Vol.238 (1), p.252-255

1997

Volltextzugriff (PDF)

PIRLINDOLE: A SELECTIVE REVERSIBLE INHIBITOR OF MONOAMINE OXIDASE A. A REVIEW OF ITS PRECLINICAL PROPERTIES

Pharmacological research, 1997-07, Vol.36 (1), p.23-33

1997

Volltextzugriff (PDF)

Efficacy and safety of the extract of Serenoa repens in the treatment of benign prostatic hyperplasia: therapeutic equivalence between twice and once daily dosage forms

Phytotherapy research, 1997-12, Vol.11 (8), p.558-563

1997

Volltextzugriff (PDF)

Facilitatory effects of chronically administered citicoline on learning and memory processes in the dog

Progress in neuro-psychopharmacology & biological psychiatry, 1998, Vol.22 (1), p.115-128

1998

Volltextzugriff (PDF)

New pyridobenzodiazepine derivatives as potential antipsychotics: synthesis and neurochemical study

Journal of medicinal chemistry, 1993-07, Vol.36 (15), p.2107-2114

1993

Volltextzugriff (PDF)

Clozapine: An atypical neuroleptic

Neuroscience and biobehavioral reviews, 1990, Vol.14 (4), p.357-363

1990

Volltextzugriff (PDF)

A double-blind randomized placebo-controlled study of the efficacy and safety of pirlindole, a reversible monoamine oxidase A inhibitor, in the treatment of depression

Acta psychiatrica Scandinavica, 1996-12, Vol.94 (6), p.404-410

1996

Volltextzugriff (PDF)

Hypochlorous Acid, a Major Oxidant Produced by Activated Neutrophils, Has Low Effect on Two Pyridobenzazepine Derivatives, JL 3 and JL 13

Archiv der Pharmazie (Weinheim), 2000-03, Vol.333 (2-3), p.63-67

2000

Volltextzugriff (PDF)

Modulation of the clozapine structure increases its selectivity for the dopamine D4 receptor

European journal of pharmacology, 1995-02, Vol.273 (3), p.R1-R3

1995

Volltextzugriff (PDF)

A Pilot Randomized Placebo-Controlled Study of Pirlindole in the Treatment of Primary Fibromyalgia

Journal of musculoskeletal pain, 1998, Vol.6 (2), p.5-17

1998

Volltextzugriff (PDF)

Effect of chronic hypoxic treatment on the retention of fixed-interval responding

Physiology & behavior, 1991-03, Vol.49 (3), p.465-470

1991

Volltextzugriff (PDF)

1 – 25 von 78

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(73)
Mit Volltextzugriff
(67)

Publikationsform

Sprache

Englisch
(76)
Französisch
(2)

Erscheinungsjahr

n.n

Thema

Science & Technology
(52)
Life Sciences & Biomedicine
(51)
Biological And Medical Sciences
(40)
Medical Sciences
(35)
Pharmacology & Pharmacy
(33)
Pharmacology. Drug Treatments
(33)
Animals
(27)
Human Health Sciences
(24)
Neuropharmacology
(24)
Pharmacie, Pharmacologie & Toxicologie
(24)
Pharmacy, Pharmacology & Toxicology
(24)
Psychology. Psychoanalysis. Psychiatry
(24)
Sciences De La Santé Humaine
(24)
Male
(23)
Humans
(21)
Psychopharmacology
(19)
Rats
(18)
Neurosciences
(17)
Neurosciences & Neurology
(17)
Behavioral Sciences
(14)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Efficacité de Dérinox ® chez des patients souffrant d’une rhinite virale évaluée par un PNIF (Peak Nasal Inspiratory Flow)

A randomized controlled clinical trial evaluating the performance and safety of platelets treated with MIRASOL pathogen reduction technology

Maintenance of remission and monotherapy status over 66 months in patients with psoriatic arthritis receiving etanercept

Nitric oxide: A new messenger in the brain

New Pyridobenzodiazepine Derivatives: Modifications of the Basic Side Chain Differentially Modulate Binding to Dopamine (D4.2, D2L) and Serotonin (5-HT2A) Receptors

B22 THAT'LL BE THE DAY: UNDERSTANDING IPF RISK FACTORS AND OUTCOMES: A European Pooled Analysis Of Epidemiological Registries In Idiopathic Pulmonary Fibrosis (ipf): Demographics And Baseline Characteristics

Pyridobenzoxazepine and Pyridobenzothiazepine Derivatives as Potential Central Nervous System Agents: Synthesis and Neurochemical Study

Electrooxidation Potential as a Tool in the Early Screening for New Safer Clozapine-like Analogues

Dopamine D4 receptors: a new opportunity for research on schizophrenia

JL13, A PYRIDOBENZOXAZEPINE COMPOUND WITH POTENTIAL ATYPICAL ANTIPSYCHOTIC ACTIVITY: A REVIEW OF ITS BEHAVIOURAL PROPERTIES

Minimal effects of JL 13, a pyridobenzoxazepine derivative with an antipsychotic potential, on circulating prolactin levels in male rats

Oxidation Sensitivity May Be a Useful Tool for the Detection of the Hematotoxic Potential of Newly Developed Molecules: Application to Antipsychotic Drugs

The inclusion of fluoxetine into γ-cyclodextrin increases its bioavailability : behavioural, electrophysiological and pharmacokinetic studies

Double-blind randomized controlled study of the efficacy and tolerability of two reversible monoamine oxidase A inhibitors, pirlindole and moclobemide, in the treatment of depression

JL 13, a Potential Successor to Clozapine, Is Less Sensitive to Oxidative Phenomena

PIRLINDOLE: A SELECTIVE REVERSIBLE INHIBITOR OF MONOAMINE OXIDASE A. A REVIEW OF ITS PRECLINICAL PROPERTIES

Efficacy and safety of the extract of Serenoa repens in the treatment of benign prostatic hyperplasia: therapeutic equivalence between twice and once daily dosage forms

Facilitatory effects of chronically administered citicoline on learning and memory processes in the dog

New pyridobenzodiazepine derivatives as potential antipsychotics: synthesis and neurochemical study

Clozapine: An atypical neuroleptic

A double-blind randomized placebo-controlled study of the efficacy and safety of pirlindole, a reversible monoamine oxidase A inhibitor, in the treatment of depression

Hypochlorous Acid, a Major Oxidant Produced by Activated Neutrophils, Has Low Effect on Two Pyridobenzazepine Derivatives, JL 3 and JL 13

Modulation of the clozapine structure increases its selectivity for the dopamine D4 receptor

A Pilot Randomized Placebo-Controlled Study of Pirlindole in the Treatment of Primary Fibromyalgia

Effect of chronic hypoxic treatment on the retention of fixed-interval responding

Suchergebnisse filtern